Search Results

You are looking at 1 - 10 of 22 items for :

  • "glucocorticoid receptor (GR)" x
Clear All
Fernando Aprile-Garcia Instituto de Investigación en Biomedicina de Buenos Aires – CONICET, Departamento de Fisiología, Partner Institute of the Max Planck Society, Buenos Aires, Argentina
Instituto de Investigación en Biomedicina de Buenos Aires – CONICET, Departamento de Fisiología, Partner Institute of the Max Planck Society, Buenos Aires, Argentina

Search for other papers by Fernando Aprile-Garcia in
Google Scholar
PubMed
Close
,
María Antunica-Noguerol Instituto de Investigación en Biomedicina de Buenos Aires – CONICET, Departamento de Fisiología, Partner Institute of the Max Planck Society, Buenos Aires, Argentina
Instituto de Investigación en Biomedicina de Buenos Aires – CONICET, Departamento de Fisiología, Partner Institute of the Max Planck Society, Buenos Aires, Argentina

Search for other papers by María Antunica-Noguerol in
Google Scholar
PubMed
Close
,
Maia Ludmila Budziñski Instituto de Investigación en Biomedicina de Buenos Aires – CONICET, Departamento de Fisiología, Partner Institute of the Max Planck Society, Buenos Aires, Argentina

Search for other papers by Maia Ludmila Budziñski in
Google Scholar
PubMed
Close
,
Ana C Liberman Instituto de Investigación en Biomedicina de Buenos Aires – CONICET, Departamento de Fisiología, Partner Institute of the Max Planck Society, Buenos Aires, Argentina

Search for other papers by Ana C Liberman in
Google Scholar
PubMed
Close
, and
Eduardo Arzt Instituto de Investigación en Biomedicina de Buenos Aires – CONICET, Departamento de Fisiología, Partner Institute of the Max Planck Society, Buenos Aires, Argentina
Instituto de Investigación en Biomedicina de Buenos Aires – CONICET, Departamento de Fisiología, Partner Institute of the Max Planck Society, Buenos Aires, Argentina

Search for other papers by Eduardo Arzt in
Google Scholar
PubMed
Close

action during inflammation (23, 24) . GCs exert their biological effects binding to the glucocorticoid receptor (GR), which is a ligand-activated TF that regulates the expression of target genes, either positively or negatively (18, 25) . In an

Open access
Kathrin Zopf Department of Endocrinology, Diabetes and Nutrition, Charité – Universitätsmedizin Berlin, Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany

Search for other papers by Kathrin Zopf in
Google Scholar
PubMed
Close
,
Kathrin R Frey Department of Medicine I, Endocrine and Diabetes Unit, University Hospital, University of Würzburg, Würzburg, Germany

Search for other papers by Kathrin R Frey in
Google Scholar
PubMed
Close
,
Tina Kienitz Department of Endocrinology, Diabetes and Nutrition, Charité – Universitätsmedizin Berlin, Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany

Search for other papers by Tina Kienitz in
Google Scholar
PubMed
Close
,
Manfred Ventz Department of Endocrinology, Diabetes and Nutrition, Charité – Universitätsmedizin Berlin, Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany

Search for other papers by Manfred Ventz in
Google Scholar
PubMed
Close
,
Britta Bauer Endocrinology in Charlottenburg, Berlin, Germany

Search for other papers by Britta Bauer in
Google Scholar
PubMed
Close
, and
Marcus Quinkler Endocrinology in Charlottenburg, Berlin, Germany

Search for other papers by Marcus Quinkler in
Google Scholar
PubMed
Close

Introduction Polymorphisms of the glucocorticoid receptor (GR) may influence the sensitivity to glucocorticoids by altering the GR expression (e.g. reducing transcription) and influencing transactivation and transrepression of target genes

Open access
Anne-Sophie C A M Koning Division of Endocrinology, Department of Medicine, Leiden University Medical Center, Leiden, The Netherlands
Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Leiden, The Netherlands

Search for other papers by Anne-Sophie C A M Koning in
Google Scholar
PubMed
Close
,
Philippe C Habets Division of Endocrinology, Department of Medicine, Leiden University Medical Center, Leiden, The Netherlands
Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Leiden, The Netherlands

Search for other papers by Philippe C Habets in
Google Scholar
PubMed
Close
,
Marit Bogaards Division of Endocrinology, Department of Medicine, Leiden University Medical Center, Leiden, The Netherlands
Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Leiden, The Netherlands

Search for other papers by Marit Bogaards in
Google Scholar
PubMed
Close
,
Jan Kroon Division of Endocrinology, Department of Medicine, Leiden University Medical Center, Leiden, The Netherlands
Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Leiden, The Netherlands

Search for other papers by Jan Kroon in
Google Scholar
PubMed
Close
,
Hanneke M van Santen Department of Pediatric Endocrinology, Wilhelmina Children’s Hospital, University Medical Center Utrecht, Utrecht, The Netherlands
Department of Pediatric Neuro-Oncology, Prinses Máxima Centrum, Utrecht, The Netherlands

Search for other papers by Hanneke M van Santen in
Google Scholar
PubMed
Close
,
Judith M de Bont Department of Pediatric Neuro-Oncology, Prinses Máxima Centrum, Utrecht, The Netherlands

Search for other papers by Judith M de Bont in
Google Scholar
PubMed
Close
, and
Onno C Meijer Division of Endocrinology, Department of Medicine, Leiden University Medical Center, Leiden, The Netherlands
Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Leiden, The Netherlands

Search for other papers by Onno C Meijer in
Google Scholar
PubMed
Close

study the biological mechanisms of action that underlie them, and this might help to decrease these adverse effects during glucocorticoid therapy. Synthetic glucocorticoids target the glucocorticoid receptor (GR), one of the two receptor types for the

Open access
Janko Sattler Adrenal Steroid Group, ANZAC Research Institute, University of Sydney, Sydney, NSW, Australia
Department of Rheumatology and Clinical Immunology, Charité-University Medicine, Berlin, Germany

Search for other papers by Janko Sattler in
Google Scholar
PubMed
Close
,
Jinwen Tu Adrenal Steroid Group, ANZAC Research Institute, University of Sydney, Sydney, NSW, Australia
Bone Research Program, ANZAC Research Institute, University of Sydney, Sydney, NSW, Australia
Concord Clinical School, The University of Sydney, Sydney, Australia

Search for other papers by Jinwen Tu in
Google Scholar
PubMed
Close
,
Shihani Stoner Bone Research Program, ANZAC Research Institute, University of Sydney, Sydney, NSW, Australia

Search for other papers by Shihani Stoner in
Google Scholar
PubMed
Close
,
Jingbao Li Bone Research Program, ANZAC Research Institute, University of Sydney, Sydney, NSW, Australia
Key Laboratory for Space Bioscience and Biotechnology, Institute of Special Environmental Biophysics, School of Life Sciences, Northwestern Polytechnical University, Shaanxi, China

Search for other papers by Jingbao Li in
Google Scholar
PubMed
Close
,
Frank Buttgereit Department of Rheumatology and Clinical Immunology, Charité-University Medicine, Berlin, Germany

Search for other papers by Frank Buttgereit in
Google Scholar
PubMed
Close
,
Markus J Seibel Bone Research Program, ANZAC Research Institute, University of Sydney, Sydney, NSW, Australia
Concord Clinical School, The University of Sydney, Sydney, Australia
Department of Endocrinology & Metabolism, Concord Hospital, Sydney, Australia

Search for other papers by Markus J Seibel in
Google Scholar
PubMed
Close
,
Hong Zhou Bone Research Program, ANZAC Research Institute, University of Sydney, Sydney, NSW, Australia
Concord Clinical School, The University of Sydney, Sydney, Australia

Search for other papers by Hong Zhou in
Google Scholar
PubMed
Close
, and
Mark S Cooper Adrenal Steroid Group, ANZAC Research Institute, University of Sydney, Sydney, NSW, Australia
Concord Clinical School, The University of Sydney, Sydney, Australia
Department of Endocrinology & Metabolism, Concord Hospital, Sydney, Australia

Search for other papers by Mark S Cooper in
Google Scholar
PubMed
Close

then blocked with 5% goat serum for 30 min and incubated overnight with the primary antibody for 11β-HSD1 (1:100, Cayman Chemicals) and glucocorticoid receptor (GR) (1:400, sc-1004, Santa Cruz Biotechnology). A biotinylated secondary antibody was

Open access
Yan-yu Zhang Department of Aquaculture, College of Marine Sciences, Hainan University, Haikou, Hainan, China

Search for other papers by Yan-yu Zhang in
Google Scholar
PubMed
Close
,
Xian Zhang Department of Aquaculture, College of Marine Sciences, Hainan University, Haikou, Hainan, China

Search for other papers by Xian Zhang in
Google Scholar
PubMed
Close
,
Shao-yang Bu Department of Aquaculture, College of Marine Sciences, Hainan University, Haikou, Hainan, China

Search for other papers by Shao-yang Bu in
Google Scholar
PubMed
Close
,
Wei-wei Zhang Department of Aquaculture, College of Marine Sciences, Hainan University, Haikou, Hainan, China

Search for other papers by Wei-wei Zhang in
Google Scholar
PubMed
Close
,
Tian-xiu Li Department of Aquaculture, College of Marine Sciences, Hainan University, Haikou, Hainan, China

Search for other papers by Tian-xiu Li in
Google Scholar
PubMed
Close
,
De-cai Zheng Department of Aquaculture, College of Marine Sciences, Hainan University, Haikou, Hainan, China

Search for other papers by De-cai Zheng in
Google Scholar
PubMed
Close
,
Ze-xiang Huang Department of Aquaculture, College of Marine Sciences, Hainan University, Haikou, Hainan, China

Search for other papers by Ze-xiang Huang in
Google Scholar
PubMed
Close
, and
Qian Wang Department of Aquaculture, College of Marine Sciences, Hainan University, Haikou, Hainan, China

Search for other papers by Qian Wang in
Google Scholar
PubMed
Close

, and kiss2 is considered to be the key regulatory gene in reproductive function ( 21 ). In goldfish, the GRE domain is found in the promoter region of kiss gene, suggesting that kisspeptin may be regulated by glucocorticoid receptor (GR) ( 43 ). It

Open access
Sirazum Choudhury Endocrinology and Investigative Medicine, Department of Metabolism, Digestion and Reproduction, Imperial College London, Commonwealth Building, London, UK
Department of Endocrinology, Imperial College Healthcare NHS Trust, London, UK

Search for other papers by Sirazum Choudhury in
Google Scholar
PubMed
Close
,
Tricia Tan Endocrinology and Investigative Medicine, Department of Metabolism, Digestion and Reproduction, Imperial College London, Commonwealth Building, London, UK
Department of Endocrinology, Imperial College Healthcare NHS Trust, London, UK

Search for other papers by Tricia Tan in
Google Scholar
PubMed
Close
,
Katharine Lazarus Endocrinology and Investigative Medicine, Department of Metabolism, Digestion and Reproduction, Imperial College London, Commonwealth Building, London, UK
Department of Endocrinology, Imperial College Healthcare NHS Trust, London, UK

Search for other papers by Katharine Lazarus in
Google Scholar
PubMed
Close
, and
Karim Meeran Endocrinology and Investigative Medicine, Department of Metabolism, Digestion and Reproduction, Imperial College London, Commonwealth Building, London, UK
Department of Endocrinology, Imperial College Healthcare NHS Trust, London, UK

Search for other papers by Karim Meeran in
Google Scholar
PubMed
Close

easily obtainable cells that are representative of peripheral tissue. They showed a 2.8-fold greater acetylation of the glucocorticoid receptor (GR) in the morning than in the evening. With acetylation of the GR attenuating the transcriptional response of

Open access
Jian Gong School of Basic Medicine, Hubei University of Chinese Medicine, Wuhan, China

Search for other papers by Jian Gong in
Google Scholar
PubMed
Close
,
Yinjuan Lv School of Basic Medicine, Hubei University of Chinese Medicine, Wuhan, China

Search for other papers by Yinjuan Lv in
Google Scholar
PubMed
Close
,
Yuhao Meng Hubei University of Chinese Medicine, Wuhan, China

Search for other papers by Yuhao Meng in
Google Scholar
PubMed
Close
,
Weiheng Zhang Hubei University of Chinese Medicine, Wuhan, China

Search for other papers by Weiheng Zhang in
Google Scholar
PubMed
Close
,
Xiaocui Jiang Hubei University of Chinese Medicine, Wuhan, China

Search for other papers by Xiaocui Jiang in
Google Scholar
PubMed
Close
, and
Min Xiao Laboratory Animal Center, Hubei University of Chinese Medicine, Wuhan, China

Search for other papers by Min Xiao in
Google Scholar
PubMed
Close

, hematoxylin-eosin (Wuhan Xavier Biotechnology Co., Ltd., Article No. GB11002, GB23303, G2020, G1121, G1076). antibody to KISS1-R protein, antibody to glucocorticoid receptor (GR) protein, antibody to Bax protein, antibody to BCL-2 protein, antibody to Caspase

Open access
Marcus Quinkler Endocrinology in Charlottenburg, Berlin, Germany

Search for other papers by Marcus Quinkler in
Google Scholar
PubMed
Close
,
Bertil Ekman Departments of Endocrinology and Medical and Health Sciences, Linköping University, Linköping, Sweden

Search for other papers by Bertil Ekman in
Google Scholar
PubMed
Close
,
Claudio Marelli Shire International GmbH, Zug, Switzerland

Search for other papers by Claudio Marelli in
Google Scholar
PubMed
Close
,
Sharif Uddin Shire, Lexington, Massachusetts, USA

Search for other papers by Sharif Uddin in
Google Scholar
PubMed
Close
,
Pierre Zelissen Department of Internal Medicine and Endocrinology, University Medical Center Utrecht, Utrecht, the Netherlands

Search for other papers by Pierre Zelissen in
Google Scholar
PubMed
Close
,
Robert D Murray Department of Endocrinology, Leeds Teaching Hospitals NHS Trust, St James’s University Hospital, Leeds, UK

Search for other papers by Robert D Murray in
Google Scholar
PubMed
Close
, and
on behalf of the EU-AIR Investigators
Search for other papers by on behalf of the EU-AIR Investigators in
Google Scholar
PubMed
Close

development of corticosteroid side effects between patients ( 7 ). Interestingly, when the endogenous glucocorticoid, cortisol (hydrocortisone), is compared with prednisolone at the isolated human glucocorticoid receptor (GR), the transactivation activity of

Open access
Masatada Watanabe Laboratory of Tissue Regeneration, Hoshi University School of Pharmacy and Pharmaceutical Sciences, Shinagawa, Tokyo, Japan

Search for other papers by Masatada Watanabe in
Google Scholar
PubMed
Close
,
Shuji Ohno Division of Research for Pharmacy Students Education, Hoshi University, Shinagawa, Tokyo, Japan

Search for other papers by Shuji Ohno in
Google Scholar
PubMed
Close
, and
Hiroshi Wachi Laboratory of Tissue Regeneration, Hoshi University School of Pharmacy and Pharmaceutical Sciences, Shinagawa, Tokyo, Japan

Search for other papers by Hiroshi Wachi in
Google Scholar
PubMed
Close

-AR signaling pathway is an increase in cyclic AMP (cAMP) concentration ([cAMP]i). An increase in [cAMP]i and activation of protein kinase A (PKA) might interfere with the action of ligand-occupied glucocorticoid receptor (GR). To better understand the mechanism

Open access
David J F Smith Department of Endocrinology, Imperial College Healthcare NHS Trust, London, UK

Search for other papers by David J F Smith in
Google Scholar
PubMed
Close
,
Hemanth Prabhudev Department of Endocrinology, Imperial College Healthcare NHS Trust, London, UK

Search for other papers by Hemanth Prabhudev in
Google Scholar
PubMed
Close
,
Sirazum Choudhury Department of Endocrinology, Imperial College Healthcare NHS Trust, London, UK
Department of Clinical Biochemistry, Imperial College Healthcare NHS Trust, London, UK
Department of Investigative Medicine, Division of Diabetes, Endocrinology and Metabolism, Imperial College London, London, UK

Search for other papers by Sirazum Choudhury in
Google Scholar
PubMed
Close
, and
Karim Meeran Department of Endocrinology, Imperial College Healthcare NHS Trust, London, UK
Department of Investigative Medicine, Division of Diabetes, Endocrinology and Metabolism, Imperial College London, London, UK

Search for other papers by Karim Meeran in
Google Scholar
PubMed
Close

mineralocorticoid production in primary adrenal failure. The mainstay of treatment is glucocorticoid replacement, with either hydrocortisone or prednisolone ( 2 ). Both work by binding to the glucocorticoid receptor (GR) for which prednisolone has the greater

Open access